Interestingly, high-risk and MYCN-amplified neuroblastoma cell lines BE(2)-C and KELLY expressing high XIAP levels, were generally sensitive to XIAP-specific antagonists A4 and B3 but were highly resistant to pan-IAP antagonist BV6 (Figs. 1A and 2A). This evidence concerns the gene MYCN and neuroblastoma.